Cypress Capital, LLC Genprex, Inc. Transaction History

Cypress Capital, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 07, 2023	BUY	$0.74 - $1.1 $74,000 - $110,000	100,000 New	100,000 $95,000
Q3 2021 Feb 10, 2022	BUY	$2.59 - $3.36 $259,000 - $336,000	100,000 New	100,000 $268,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $64.3M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Cypress Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital, LLC with notifications on news.